Products & deployments
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, has announced findings from a newly published, first-of-its-kind comparative study of single-use negative pressure wound therapy (sNPWT) devices in orthopedic and cardiovascular surgery. Analysing real-world data from over 22,000 patients in the Premier PINC AI™ Healthcare Database, the analysis reveals that prophylactic use of PICO sNPWT (-80 [...]
Pharmaceutical Press, the Royal Pharmaceutical Society’s knowledge business, will showcase Stockley's Drug Interactions, practical evidence-based information to manage drug interactions safely and effectively, at this year’s Global Health Exhibition in Riyadh, highlighting its crucial role in addressing medication errors. As part of the Association of British HealthTech Industries (ABHI) UK Pavilion (Hall 3, Stand L40), [...]
Imprivata has announced the acquisition of Verosint, a leader in Identity Threat Detection and Response (ITDR) solutions. The acquisition represents Imprivata’s latest strategic investment in modernising enterprise access management with solutions that deliver advanced, frictionless, and passwordless access for every user type, including frontline staff, knowledge workers, and third-party identities, while strengthening security, streamlining compliance, [...]
Built on 1.3 billion structured data points shared by over 3 million people living with 1,250 chronic conditions, OpenStuff transforms lived patient health experiences into real-time, actionable insights. More than half of U.S. adults report turning to social media for health information, yet over one-third encounter high levels of misinformation. Large language models now risk [...]
UK digital health innovator Aide Health has launched Mirror, the UK’s first AI-powered scribe for patients, tackling the widespread problem of medical advice being forgotten or misunderstood after appointments. Research shows up to 80 per cent of medical details are forgotten immediately, and of the small amount remembered, nearly half is recalled inaccurately. This problem [...]
The Royal Wolverhampton NHS Trust has successfully gone live with System C’s CareFlow Electronic Patient Record (EPR), a significant step forward in its landmark digital transformation programme. Delivered through the trust’s Blueprint project, the phased initiative is unify several legacy systems into a single, trust-wide platform – modernising how patient information is managed across New [...]
Barts Health NHS Trust is transforming maternity care for over 14,000 families annually by adopting BadgerNet as its digital maternity solution in a new five-year partnership. As one of England’s largest NHS trusts, Barts Health serves a diverse East London population and has maternity services at three hospitals; Whipps Cross, Newham Hospital and The Royal [...]
An innovative technology developed by researchers in the UK has received over £475,000 in funding to revolutionise how eczema is diagnosed and treated, potentially ending years of suffering for millions of patients across the UK. The innovative vibroacoustic sensor, which measures material changes in each layer of skin using small vibrations on the surface, has [...]
Transform, the UK’s leading clinic for orthopaedic, cosmetic and elective surgery, today announces the launch of Transform Femme, a pioneering new service providing first-class treatment for a wide range of gynaecological concerns. Launching in October 2025, Transform Femme will be available at Transform’s state-of-the-art Electiva Hospitals in Manchester, Glasgow, Newcastle and London as well as through specialist [...]
Amorphical, developer of nano-amorphous mineral-based pharmacologic agents for health conditions, has announced positive interim results from its ongoing open-label clinical trial evaluating its investigational therapy for the treatment of moderate-to-severe Crohn’s disease. The data suggests that the investigational therapy, when added to best available therapy, supports meaningful clinical improvement and remission. The drug has been [...]
